FDA-Drug2025-10-15Class II
Bevacizumab 1.75 mg/0.07 mL - 0.25 mL syringe, Intravitreal, 0.07 mL Total Volume, Rx Only, Hospital/Office Use Only, Refrigerate, RC Outsourcing LLC, Lowellville, OH 44436.
Hazard
Lack of assurance of sterility.
Sold states
Nationwide in the US
Affected count
2,669 syringes
Manufactured in
102 E Water St, Lowellville, OH, United States
Products
Bevacizumab 1.75 mg/0.07 mL - 0.25 mL syringe, Intravitreal, 0.07 mL Total Volume, Rx Only, Hospital/Office Use Only, Refrigerate, RC Outsourcing LLC, Lowellville, OH 44436.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0003-2026Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief